Market closedNon-fractional
MeiraGTx/MGTX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About MeiraGTx
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
Ticker
MGTX
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
New York, United States
Employees
402
Website
meiragtx.com
MeiraGTx Metrics
BasicAdvanced
$259M
Market cap
-
P/E ratio
-$1.23
EPS
1.31
Beta
-
Dividend rate
Price and volume
Market cap
$259M
Beta
1.31
Financial strength
Current ratio
3.14
Quick ratio
3.014
Long term debt to equity
69.157
Total debt to equity
72.597
Interest coverage (TTM)
-11.32%
Management effectiveness
Return on assets (TTM)
-31.82%
Return on equity (TTM)
-69.92%
Valuation
Price to revenue (TTM)
21.316
Price to book
2.13
Price to tangible book (TTM)
2.15
Price to free cash flow (TTM)
-2.056
Growth
Revenue change (TTM)
-16.45%
Earnings per share change (TTM)
-55.83%
3-year revenue growth
-10.64%
3-year earnings per share growth
-9.61%
What the Analysts think about MeiraGTx
Analyst Ratings
Majority rating from 5 analysts.
MeiraGTx Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$600K
-70.00%
Net income
-$20M
-200.99%
Profit margin
-3,400.00%
-436.63%
MeiraGTx Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.53
-$0.74
-$0.42
-$0.32
-
Expected
-$0.57
-$0.55
-$0.11
-$0.51
-$0.40
Surprise
-6.47%
35.37%
270.59%
-36.63%
-
MeiraGTx News
AllArticlesVideos
![MeiraGTx Reports First Quarter 2024 Financial and Operational Results](https://cdn.snapi.dev/images/v1/n/d/press3-2420659.jpg)
MeiraGTx Reports First Quarter 2024 Financial and Operational Results
GlobeNewsWire·2 months ago
![MeiraGTx to Participate in Upcoming Investor Conferences](https://cdn.snapi.dev/images/v1/s/z/conf3-2389504.jpg)
MeiraGTx to Participate in Upcoming Investor Conferences
GlobeNewsWire·2 months ago
![MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference](https://cdn.snapi.dev/images/v1/e/t/press6-2379524.jpg)
MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference
GlobeNewsWire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for MeiraGTx stock?
MeiraGTx (MGTX) has a market cap of $259M as of July 06, 2024.
What is the P/E ratio for MeiraGTx stock?
The price to earnings (P/E) ratio for MeiraGTx (MGTX) stock is 0 as of July 06, 2024.
Does MeiraGTx stock pay dividends?
No, MeiraGTx (MGTX) stock does not pay dividends to its shareholders as of July 06, 2024.
When is the next MeiraGTx dividend payment date?
MeiraGTx (MGTX) stock does not pay dividends to its shareholders.
What is the beta indicator for MeiraGTx?
MeiraGTx (MGTX) has a beta rating of 1.31. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
![Buy or sell MeiraGTx stock](/_next/image?url=%2Fresources%2Fimages%2Fpromo_phone.png&w=256&q=75)
Buy or sell MeiraGTx stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.